Podocytopathy and Nephrotic Syndrome in Mice with Podocyte-Specific Deletion of the Asah1 Gene Role of Ceramide Accumulation in Glomeruli
AMERICAN JOURNAL OF PATHOLOGY
Authors: Li, Guangbi; Kidd, Jason; Kaspar, Cristin; Dempsey, Sara; Bhat, Owais M.; Camus, Sarah; Ritter, Joseph K.; Gehr, Todd W. B.; Gulbins, Erich; Li, Pin-Lan
Abstract
Lysosomal acid ceramidase (Ac) has been shown to be critical for ceramide hydrolysis and regulation of lysosome function and cellular homeostasis. In the present study, we generated a knockout mouse strain (Asah1(fl/fl)/Podo(Cre)) with a podocyte-specific deletion of the alpha subunit (main catalytic subunit) of Ac. Although no significant morphologic changes in glomeruli were observed in these mice under light microscope, severe proteinuria and albuminuria were found in these podocyte-specific knockout mice compared with control genotype littermates. Transmission electron microscopic analysis showed that podocytes of the knockout mice had distinctive foot process effacement and microvillus formation. These functional and morphologic changes indicate the development of nephrotic syndrome in mice bearing the Asah1 podocyte-specific gene deletion. Ceramide accumulation determined by liquid chromatography-tandem mass spectrometry was demonstrated in isolated glomeruli of Asah1(fl/fl)/Podo(Cre) mice compared with their littermates. By crossbreeding Asah1(fl/fl)/Podo(Cre) mice with Smpd1(-/-) mice, we also produced a double knockout strain, Smpd1(-/-)/Asah1(fl/fl)/Podo(Cre), that also lacks Smpd1, the acid sphingomyelinase that hydrolyzes sphingomyelin to ceramide. These mice exhibited significantly lower levels of glomerular ceramide with decreased podocyte injury compared with Asah1(fl/fl)/Podo(Cre) mice. These results strongly suggest that lysosomal Ac in podocytes is essential for the maintenance of the structural and functional integrity of podocytes.
Genomics and epigenetics: A study of ependymomas in pediatric patients.
CLINICAL NEUROLOGY AND NEUROSURGERY
Authors: Perez-Ramirez, Monserrat; Justino Hernandez-Jimenez, Alejo; Guerrero-Guerrero, Armando; Benadon-Darszon, Eduardo; Perezpena-Diazconti, Mario; Georgina Siordia-Reyes, Alicia; Garcia-Mendez, Antonio; Chico-Ponce de Leon, Fernando; Abdel Salamanca-Gomez, Fabio; Garcia-Hernandez, Normand
Abstract
Objective: We identify chromosomal alterations, the methylation pattern and gene expression changes in pediatric ependymomas. Methods: CGH microarray, methylation and gene expression were performed through the Agilent platform. The results were analyzed with the software MatLab, MapViewer, DAVID, GeneCards and Hippie. Results: Amplification was found in 14q32.33, 2p22.3 and 8p22, and deletion was found in 8p11.23-p11.22 and 1q21.3. We observed 42.387 CpG islands with changes in their methylation pattern, in which we found 272 genes involved in signaling pathways related to carcinogenesis. We found 481 genes with altered expression. The genes IMMT,JHDMD1D, ASAH1, ZWINT, IPO7, GNAO1 and CISD3 were found to be altered among the three levels. Conclusion: The 2p22.3, 8p11.23-p11.22 and 14q32.33 regions were identified as the most important; the changes in the methylation pattern related to cell cycle and cancer genes occurred in MIB2, FGF18 and ITIH5. The IPO7, GNAO1 and ASAH1 genes may play a major role in ependymoma development. (C) 2016 Elsevier B.V. All rights reserved.